Expression and Clinical Significance of Class Ⅰ Histone Deacetylases in the Serum of Patients With Psoriatic Arthritis

Minghui ZHANG; Wenxiu DONG; Jia WANG; Gailian ZHANG

doi:10.3881/j.issn.1000-503X.16499

PDF(924 KB)

Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (4) : 557-566. DOI: 10.3881/j.issn.1000-503X.16499

Original Articles

Expression and Clinical Significance of Class Ⅰ Histone Deacetylases in the Serum of Patients With Psoriatic Arthritis

Minghui ZHANG ¹^,² ,
Wenxiu DONG ² ,
Jia WANG ² ,
Gailian ZHANG ¹^,²

Author information +

History +

Abstract

Objective To investigate the expression levels of class Ⅰ histone deacetylases(HDAC)in the serum of patients with newly diagnosed psoriatic arthritis(PsA)and screen out serological indicators that are of significance for early diagnosis and assessment of disease activity.Methods A total of 49 PsA patients newly diagnosed in Shanxi Provincial People’s Hospital from August 2022 to February 2024 and 30 healthy individuals(control group)were enrolled in this study.Demographic data were collected,and disease severity was assessed.Serum samples were collected,and the expression levels of class Ⅰ HDAC(HDAC1,HDAC2,HDAC3,and HDAC8)in the serum of each group were determined by ELISA.The correlations between the expression levels of class Ⅰ HDAC and clinical assessment indicators in each group were evaluated.Multivariate Logistic regression was adopted to analyze the risk factors affecting the disease activity of PsA patients.The receiver operating characteristic curve was used to evaluate the diagnostic efficacy of the risk factors affecting the disease activity of PsA patients.Results Compared with the control group,PsA patients showed up-regulated expression levels of HDAC1(P=0.003),HDAC2(P=0.010),HDAC3(P=0.003),and HDAC8(P=0.018)in the serum.The serum HDAC1 level of PsA patients was positively correlated with erythrocyte sedimentation rate(r=0.344,P=0.028).The serum HDAC2 level was positively correlated with the overall assessment of disease activity(r=0.468,P=0.001),the disease activity index of arthritis(r=0.401,P=0.007),the number of swollen joints(r=0.308,P=0.042),hospital anxiety and depression scale(HADS)score of anxiety(r=0.360,P=0.018),and HADS score of depression(r=0.302,P=0.047).The serum HDAC3 level was correlated with erythrocyte sedimentation rate(r=0.542,P<0.001),C-reactive protein(CRP)level(r=0.440,P<0.001),HADS score of anxiety(r=0.420,P=0.005),interleukin-6 level(r=0.397,P=0.004),the overall assessment of disease activity(r=0.318,P=0.036),and the course of psoriatic arthritis(r=0.330,P=0.028).The serum HDAC8 level was positively correlated with HADS score of anxiety(r=0.477,P=0.008)and erythrocyte sedimentation rate(r=0.385,P=0.039).Compared with the patients with low disease activity,those with moderate to high disease activity presented up-regulated expression of HDAC3(P=0.041).HDAC2(P=0.028)and CRP(P=0.034)were risk factors for moderate to high disease activity in PsA patients.HDAC2(area under the curve=0.802,P=0.003)and CRP(area under the curve=0.718,P=0.033)had diagnostic value for the progression of PsA.Conclusions The expression levels of class Ⅰ HDAC in the serum of patients with newly diagnosed PsA were significantly different.The serum levels of HDAC2 and CRP are expected to become serological indicators for the early diagnosis and disease activity assessment of PsA.

Key words

psoriatic arthritis / histone deacetylase / disease activity

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Minghui ZHANG , Wenxiu DONG , Jia WANG , et al. Expression and Clinical Significance of Class Ⅰ Histone Deacetylases in the Serum of Patients With Psoriatic Arthritis[J]. Acta Academiae Medicinae Sinicae. 2025, 47(4): 557-566 https://doi.org/10.3881/j.issn.1000-503X.16499

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Schett G, Rahman P, Ritchlin C, et al. Psoriatic arthritis from a mechanistic perspective[J]. Nat Rev Rheumatol, 2022, 18(6):311-325.DOI:10.1038/s41584-022-00776-6. Cited in this article [1]

[2]	Lee BW, Moon SJ. Inflammatory cytokines in psoriatic arthritis:understanding pathogenesis and implications for treatment[J]. Int J Mol Sci, 2023, 24(14):11662.DOI:10.3390/ijms241411662. Cited in this article [1]

[3]	《中国关节病型银屑病诊疗共识(2020)》编写委员会专家组. 中国关节病型银屑病诊疗共识(2020)[J]. 中华皮肤科杂志, 2020, 53(8):585-595.DOI:10.35541/cjd.20200369. Cited in this article [1]

[4]	FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis[J]. Nat Rev Dis Primers, 2021, 7(1):59.DOI:10.1038/s41572-021-00293-y. Cited in this article [1]

[5]	苏茵, 王彩虹, 高晋芳, 等. 银屑病关节炎诊疗规范[J]. 中华内科杂志, 2022, 61(8):883-892.DOI:10.3760/cma.j.cn112138-20220103-00003. Cited in this article [1]

[6]	Skornicki M, Prince P, Suruki R, et al. Clinical burden of concomitant joint disease in psoriasis:a US-linked claims and electronic health records database analysis[J]. Adv Ther, 2021, 38(5):2458-2471.DOI:10.1007/s12325-021-01698-7. Cited in this article [1]

[7]	Maximilian R, Garbe C, Petersen J, et al, Comorbidity and risk factors for psoriatic arthritis:a health insurance claims database analysis[J]. Acta Derm Venereol, 2021, 101(10):adv00566.DOI:10.2340/00015555-3879. Cited in this article [1]

[8]

Naye

, Toupin-April

, de Wit

, et al. Omeract core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions:a scoping review to identify candidate instruments[J]. Semin Arthritis Rheum, 2024,65:152344.DOI:10.1016/j.semarthrit.2023.152344.

Cited in this article [1]

[9]	Ding Q, Hu W, Wang R, et al. Signaling pathways in rheumatoid arthritis:implications for targeted therapy[J]. Signal Transduct Target Ther, 2023, 8(1):68.DOI:10.1038/s41392-023-01331-9. Cited in this article [1]

[10]	Grabiec AM, Reedquist KA. Histone deacetylases in RA: epigenetics and epiphenomena[J]. Arthritis Res Ther, 2010, 12(5):142.DOI:10.1186/ar3137. Cited in this article [1]

[11]	Singh JA, Guyatt G, Ogdie A, et al, Special article:2018 american college of rheumatology/national psoriasis foundation guideline for the treatment of psoriatic arthritis[J]. Arthritis Rheumatol, 2019, 71(1):5-32.DOI:10.1002/art.40726. Cited in this article [1]

[12]	Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid[J]. Dermatologica, 1978, 157(4):238-244.DOI:10.1159/000250839. Cited in this article [1]

[13]	Schoels M, Aletaha D, Alasti F, et al. Disease activity in psoriatic arthritis(PsA):defining remission and treatment success using the DAPSA score[J]. Ann Rheum Dis, 2016, 75(5):811-818.DOI:10.1136/annrheumdis-2015-207507. Cited in this article [1]

[14]	Zigmond AS, Snaith RP. The hospital anxiety and depression scale[J]. Acta Psychiatr Scand, 1983, 67(6):361-370.DOI:10.1111/j.1600-0447. Cited in this article [1]

[15]	Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone protein acetylation[J]. Nat Rev Mol Cell Biol, 2022, 23(5):329-349.DOI:10.1038/s41580-021-00441-y. Cited in this article [1]

[16]	Munro SK, Balakrishnan B, Lissaman AC, et al. Cytokines and pregnancy:potential regulation by histone deacetylases[J]. Mol Reprod Dev, 2021, 88(5):321-337.DOI:10.1002/mrd.23430. Cited in this article [1]

[17]	卢美美, 武新荣, 赵勇. 鼻咽癌组织中HDAC1、HDAC7及ZNF191蛋白表达情况及其临床价值[J]. 实用癌症杂志, 2024, 39(12):1966-1968.DOI:10.3969/j.issn.1001-5930.2024.12.011. Cited in this article [1]

[18]	刘明华, 徐金勇, 王培培. 支气管哮喘并发肺部感染患儿血清HDAC1、KLF5水平及意义[J]. 检验医学与临床, 2024, 21(16):2340-2344.DOI:10.3969/j.issn.1672-9455.2024.16.008. Cited in this article [1]

[19]	冯瑞丰, 林振涛, 杨中鹏, 等. 血清HDAC2、sST2对职业性哮喘患者的预后评估价值[J]. 环境与职业医学, 2024, 41(11):1221-1226.DOI:10.11836/JEOM24061. Cited in this article [1]

[20]	黄静, 杨晶晶, 徐彦超, 等. 急性髓系白血病患者血清HDAC2的表达及其临床意义[J]. 中国实验血液学杂志, 2024, 32(5):1317-1322.DOI:10.19746/j.cnki.issn1009-2137.2024.05.003. Cited in this article [1]

[21]	宋世雄, 牛荣荣, 宋蕾, 等. 血清HDAC3、CX3CL1水平与帕金森患者病情严重程度的关系[J]. 检验医学与临床, 2024, 21(23):3541-3545.DOI:10.3969/j.issn.1672-9455.2024.23.022. Cited in this article [1]

[22]	武云慧, 董敬超, 张雪棉, 等. 急性病毒性肝炎患者血清HDAC3和HDAC11表达与T细胞淋巴亚群的关系研究[J]. 中国急救复苏与灾害医学杂志, 2024, 19(11):1500-1503,1535. Cited in this article [1]

[23]	章则陈, 刘艳群, 雷育军. 血清APPL1和HDAC3水平对慢性心力衰竭病人心功能和预后的预测价值[J]. 中西医结合心脑血管病杂志, 2024, 22(17):3176-3180.DOI:10.12102/JI.SSN.1672-1349.2024.17.018. Cited in this article [1]

[24]	叶铮, 姚娜, 徐芳琳. CTD相关ILD患者血清中HDAC3水平及临床意义[J]. 中国医学创新, 2024, 21(28):149-152.DOI:10.3969/j.issn.1674-4985.2024.28.035. Cited in this article [2]

[25]	李美, 王胜杰, 王霞, 等. 骨关节炎患者血清HDAC3表达水平及临床意义[J]. 国际检验医学杂志, 2024, 45(9):1085-1088,1095.DOI:10.3969/j.issn.1673-4130.2024.09.012. Cited in this article [1]

[26]	Ovejero-Benito MC, Reolid A, Sánchez-Jiménez P, et al. Histone modifications associated with biological drug response in moderate-to-severe psoriasis[J]. Exp Dermatol, 2018, 27(12):1361-1371.DOI:10.1111/exd.13790. Cited in this article [1]

[27]	Gschl L, Preglej T, Boucheron N, et al. Histone deacetylase 1(HDAC1):a key player of T cell-mediated arthritis[J]. J Autoimmun, 2020,108:102379.DOI:10.1016/j.jaut.2019.102379. Cited in this article [2]

[28]	Tovar-Castillo LE, Cancino-Díaz JC, García-Vázquez F, et al. Under-expression of VHL and over-expression of HDAC-1,HIF-1alpha,Ⅱ-37,and IAP-2 in affected skin biopsies of patients with psoriasis[J]. Int J Dermatol, 2007, 46(3):239-246.DOI:10.1111/j.1365-4632.2006.02962.x. Cited in this article [1]

[29]	Hwang YJ, Na JI, Byun SY, et al. Histone deacetylase 1 and sirtuin 1 expression in psoriatic skin:a comparison between guttate and plaque psoriasis[J]. Life(Basel), 2020, 10(9):157.DOI:10.3390/life10090157. Cited in this article [1]

[30]	Kawabata T, Nishida K, Takasugi K, et al. Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis[J]. Arthritis Res Ther, 2010, 12(4):R133.DOI:10.1186/ar3071. Cited in this article [1]

[31]	Algate K, Haynes D, Fitzsimmons T, et al. Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro[J]. J Cell Biochem, 2020, 121(1):244-258.DOI:10.1002/jcb.29137. Cited in this article [1]

[32]

Meng

, Pan

, Sheng

. Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis[J]. Clin Exp Rheumatol, 2021, 39(5):970-981.DOI:10.55563/ClinExprheumatol/1xsigp.

Cited in this article [1]

[33]	Li Y, Zhou M, Lv X, et al. Reduced activity of HDAC3 and increased acetylation of histones H3 in peripheral blood mononuclear cells of patients with rheumatoid arthritis[J]J Immunol Res, 2018,2018:7313515.DOI:10.1155/2018/7313515. Cited in this article [1]

[34]	Yao F, Zhao Y, Yu Q, et al. Extracellular CIRP induces abnormal activation of fibroblast-like synoviocytes from patients with RA via the TLR4-mediated HDAC3 pathways[J]. Int Immunopharmacol, 2024,128:111525.DOI:10.1016/j.intimp.2024.111525. Cited in this article [1]

[35]	Yuan H, Jiao L, Yu N, et al. Histone deacetylase 3-mediated inhibition of microRNA-19a-3p facilitates the development of rheumatoid arthritis-associated interstitial lung disease[J]. Front Physiol, 2020,11:549656.DOI:10.3389/fphys.2020.549656. Cited in this article [1]

[36]	Tordera RM, Cortés-Erice M. Role of histone deacetylases in monocyte function in health and chronic inflammatory diseases[J]. Rev Physiol Biochem Pharmacol, 2021,180:1-47.DOI:10.1007/112_2021_59. Cited in this article [1]

[37]	Angiolilli C, Grabiec AM, Ferguson BS, et al. Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression[J]. Ann Rheum Dis, 2016, 75(2):430-438.DOI:10.1136/annrheumdis-2014-205635. Cited in this article [1]

[38]	Mao D, Jiang H, Zhang F, et al. HDAC2 exacerbates rheumatoid arthritis progression via the IL-17-CCL7 signaling pathway[J]. Environ Toxicol, 2023, 38(7):1743-1755.DOI:10.1002/tox.23802. Cited in this article [1]

[39]	Kim DS, Kwon JE, Lee SH, et al. Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells[J]. Front Immunol, 2018,9:1525.DOI:10.3389/fimmu.2018.01525. Cited in this article [1]

[40]	Dou C, Li N, Ding N, et al. HDAC2 regulates FoxO1 during RANKL-induced osteoclastogenesis[J]. Am J Physiol Cell Physiol, 2016, 310(10):C780-C787.DOI:10.1152/ajpcell.00351. Cited in this article [1]

[41]	Olson ME, Hornick MG, Stefanski A, et al. A biofunctional review of C-reactive protein(CRP)as a mediator of inflammatory and immune responses:differentiating pentameric and modified CRP isoform effects[J]. Front Immunol, 2023,14:1264383.DOI:10.3389/fimmu.2023.1264383. Cited in this article [1]

[42]	Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP:why they are more than inflammatory biomarkers,and why it matters[J]. Brain Behav Immun, 2018, 70:61-75.DOI:10.1016/j.bbi.2018.02.013. Cited in this article [1]